RNA interference provides enormous potential for the treatment of several diseases, including cancer. Nevertheless, successful therapies based on siRNA require overcoming various challenges, such as poor pharmacokinetic characteristics of the small RNA molecule and inefficient cytosolic accumulation. In this respect, the development of functional siRNA carrier systems is a major task in biomedical research. To provide such a desired system, the synthesis of 3-arm and 6-arm PeptoStars is aimed for. The different branched polypept(o)idic architectures share a stealth-like polysarcosine corona for efficient shielding and a multifunctional polylysine core, which can be independently varied in size and functionality for siRNA complexation-, tran...
Designing synthetic macromolecular vehicles with high transfection efficiency and low cytotoxicity h...
Despite effective gene silencing in vitro, in vivo delivery and transfection of siRNA remain challen...
RNA interference (RNAi) is a highly specific gene-silencing mechanism triggered by small interfering...
Cancer is one of the most common causes of death worldwide. Two types of cancer that have high morta...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
RNA interference has broad therapeutic potential due to its high specificity and ability to potentia...
RNA interference (RNAi) by small interfering RNAs (siRNAs) is a promising therapeutic approach. Beca...
Although our understanding of RNAi and our knowledge on designing and synthesizing active and safe s...
Small interfering RNAs (siRNAs) have recently emerged as a new class of biopharmaceuticals for the t...
The process of RNA interference (RNAi) is a natural phenomenon posttranscriptionally controlling gen...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
The development of pharmaceutical technology has enabled the treatment of diseases that were once co...
Small interfering RNAs (siRNAs) are a promising class of RNA directed therapeutics. While exerting t...
A new siRNA delivery system using a cationic glyco-star polymer is described. Spermine-modified 8-ar...
Copyright © 2015 Tomoki Nishimura et al. This is an open access article distributed under the Creati...
Designing synthetic macromolecular vehicles with high transfection efficiency and low cytotoxicity h...
Despite effective gene silencing in vitro, in vivo delivery and transfection of siRNA remain challen...
RNA interference (RNAi) is a highly specific gene-silencing mechanism triggered by small interfering...
Cancer is one of the most common causes of death worldwide. Two types of cancer that have high morta...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
RNA interference has broad therapeutic potential due to its high specificity and ability to potentia...
RNA interference (RNAi) by small interfering RNAs (siRNAs) is a promising therapeutic approach. Beca...
Although our understanding of RNAi and our knowledge on designing and synthesizing active and safe s...
Small interfering RNAs (siRNAs) have recently emerged as a new class of biopharmaceuticals for the t...
The process of RNA interference (RNAi) is a natural phenomenon posttranscriptionally controlling gen...
The delivery of small interfering RNA (siRNA) remains a major hurdle for the clinical translation of...
The development of pharmaceutical technology has enabled the treatment of diseases that were once co...
Small interfering RNAs (siRNAs) are a promising class of RNA directed therapeutics. While exerting t...
A new siRNA delivery system using a cationic glyco-star polymer is described. Spermine-modified 8-ar...
Copyright © 2015 Tomoki Nishimura et al. This is an open access article distributed under the Creati...
Designing synthetic macromolecular vehicles with high transfection efficiency and low cytotoxicity h...
Despite effective gene silencing in vitro, in vivo delivery and transfection of siRNA remain challen...
RNA interference (RNAi) is a highly specific gene-silencing mechanism triggered by small interfering...